S.I. No. 212/2023 - Greyhound Racing (Prohibited Substances) Regulations 2023

Type Statutory Instrument
Publication 2023-05-05
State In force
Text As published
articles 6

This is the act as published. Later amendments are not folded into the text below: each one is a separate act in this repository and an entry in this law's history.

Reform history JSON API

Notice of the making of this Statutory Instrument was published in

“Iris Oifigiúil” of 5th May, 2023.

Rásaíocht Con Éireann, in exercise of the powers conferred on it by section 27 of the Greyhound Racing Act 2019 (No. 15 of 2019), after consultation with the Minister for Agriculture, Food and the Marine, hereby makes the following regulations:

Citation, collective citation and commencement

1.

1.

These Regulations may be cited as the Greyhound Racing (Prohibited Substances) Regulations 2023.

2.

2.

The following provisions of the Greyhound Industry (Racing) Regulations 2007 (S. I. No. 302 of 2007) are revoked, namely:

3.

3.

The Greyhound Industry (Racing) (Amendment no.2) Regulations 2015 (S. I. No. 396 of 2015) are revoked.

4.

4.

The following provisions of the Greyhound Industry (Racing) Regulations 2016 (S. I. No. 440 of 2016) are revoked, namely:

5.

5.

These Regulations come into operation on the 7th day of May of 2023.

Definitions

2.

In these Regulations:

“the Act of 2019” means the Greyhound Racing Act 2019 (No. 15 of 2019).

“adverse analytical finding’ means a finding of a prohibited substance following the analysis of a sample taken in accordance with Regulation 4 and analysed by an approved laboratory;

“approved laboratory” means a laboratory approved by the Board under Regulation 4(6);

“control steward” means a person appointed under permit granted by the Board to fulfil the duties of an authorised officer under the Act of 2019 and the duties assigned to a control steward under these Regulations and the Greyhound Industry (Racing) Regulations 2007 to 2021 or any subsequent amendment thereto.

“faultless exposure” means exposure of the greyhound to the prohibited substance from environmental sources, dietary contamination or similar means.

“meeting” means a greyhound race meeting held at a greyhound race track “principal act” means the Greyhound Industry Act (No 12 of 1958).

“prohibited substance” means a substance or class of substance listed in Part 1, or a substance or class of substance listed in Part 2, of the Schedule and prohibited to be administered to a greyhound under Regulation 3. A finding of a prohibited substance means a finding of the substance itself, a metabolite of the substance, an isomer of the substance, or an isomer of a metabolite of the substance.

“race” in relation to a meeting, means a competition on a greyhound race track in which an object propelled by mechanical means is pursued by the greyhounds engaged in the competition and on the result of which a prize in money or money’s worth is awarded to the winning or placed greyhounds;

“race track executive” in relation a greyhound race track, means the licensee under the greyhound race track licence”

“stewards of the meeting” means the control steward and the stewards appointed by a race track executive, with the approval of the Board, to carry out such duties as may be assigned to them.

“trial” means a test run on a greyhound race track in which an object propelled by mechanical means is pursued by the greyhounds taking part in the test;

“veterinary medicinal product” means a veterinary medicinal product within the meaning of Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 20181 .

Prohibited substances

3.

(1) Subject to paragraph (2) the administration of a class of substance listed in Part 1, or a substance listed in column (1), at the level specified opposite in column (2), of Part 2, of the Schedule, to a greyhound is prohibited.

Sampling for prohibited substances

4.

(1) In this Regulation “designated person” means—

Records

5.

(1) A person who keeps a greyhound eligible for a race or trial shall—

Announcement of testing of greyhounds at meetings

6.

6.

The names of greyhounds selected for testing at a race meeting or trial may be publicly announced.

Schedule Prohibited Substances

Part I - Classes of substances

Anabolic Steroids; Beta –blockers; Beta-agonists, unless specified in the Second Schedule; Benzodiazepines Antidepressants Central Nervous System Stimulants Phosphodiesterase (PDE5) inhibitors; Noradrenaline agonists including but not limited to substances such as Amphetamines, unless specified in the Second Schedule.

Part 2 - Substances

Name of substance (1) Level of substance accepted as faultless exposure (if any). Where zero level is set out then no faultless exposure is accepted for that substance (2)
Amphetamine zero
Azaperone zero
Benzoylecgonine (in the presence of other diagnostic metabolites of cocaine) 20.0 ng/ml in urine
Benzylpiperazine zero
Bromantane and Hydroxybromantane zero
Boldenone and metabolites Boldenone 1,4-androstadien-3,17-dione (Androstadiendione/Boldione) 5β-androst-1-en-17β-ol-3-one zero
Cinchopen zero
Chlorpromazine zero
Clenbuterol zero
Cocaine zero
Cyclizine zero
Danazol & its Metabolites Danazol (4-androsten-[2,3,d]-isoxazole-17β-ethynyl-17β-ol); Ethisterone (4-androsten-17α-ethynyl-17β-ol-3-one) zero
Diclofenac zero
Diflunisal zero
Ephedrine zero
Erythropoietin (EPO) zero
Ethylestranol & Metabolites Ethylestranol (4-estren-17α-ethyl-17β-ol) zero
Fenoprofen zero
Flufenamic acid zero
Flunixin 50 ng/ml in urine
Ibuprofen zero
Ketoprofen 65 ng/ml in urine
Levorphanol zero
Meclofenamic acid zero
Mefenamic acid zero
Mesterolone & Metabolites Mesterolone (5α-androstane-1α-methyl-17β-ol-3-one); 1α-methyl-5α-androstan-3β,17β-diol zero
Mephentermine zero
Methamphetamine zero
Methylphenidate zero
Methyltestosterone& Metabolites 17α -Methyltestosterone; 5α-androstan-17α-methyl-3β,17β-diol (Methylandrostanediol); zero
Morphine 1μg/ml in urine
Naftidrofuryl zero
Nandrolone & Metabolites Nandrolone (19- nortestosterone) 19-norandrosterone 19-norepiandrosterone 19-noretiocholanolone 5α-estran-3β,17β-diol 5β-estran-3α,17β-diol 5α-estran-3β,17α-diol zero
Naproxen zero
Nikethamide zero
Nimesulide zero
Norethandrolone & Metabolites Norethandrolone (4-estren-17α-ethyl-17β-ol-3-one); 19-nor-5α,17α-pregnane-3β,17β-diol zero
Phentermine zero
Piroxicam zero
Propanolol zero
Sildenafil zero
Stanozolol (6 a-hydroxystanozolol) zero
Timolol zero
Vardenafil zero

Given under the Seal of Rásaíocht Con Éireann

27^th day of April 2023

FRANK NYHAN,

Chairman of the Board

JOHN TUOHEY

Chief Executive of the Board

An officer authorised by the Board to authenticate the Seal of the Board.

EXPLANATORY NOTE

(This note is not part of the Instrument and does not purport to be a legal interpretation)

These Regulations set out the procedures under which greyhound racing sampling and subsequent analysis will be conducted on samples procured at greyhound race tracks and at such places used for the public sale of greyhounds, the training or breeding of greyhounds, or at any premises where greyhounds are maintained.

Footnotes

1

OJ No. L4,7.1.2019, p.43

This document does not substitute the official text published in the Irish Statute Book. We accept no responsibility for any inaccuracies arising from the transcription of the original into this format.

This text is published under Irish Statute Book's own terms of reuse, not a Legalize or public-domain licence. Irish Statute Book
CC-BY 4.0 (Oireachtas Open Data PSI Licence)
Contains Irish Public Sector Information licensed under the Oireachtas (Houses of the Oireachtas) Open Data PSI Licence / Creative Commons Attribution 4.0 International, sourced from https://www.irishstatutebook.ie.